Guangzhou Jiankangyuan Respiratory Medicine Engineering

Guangzhou Joincare Respiratory Medicine Engineering is a specialized pharmaceutical subsidiary of Joincare Pharmaceutical Group, dedicated to the research, development, and large-scale production of inhalation therapies. Based in Guangzhou, China, the company focuses on high-barrier respiratory medications for conditions such as asthma and chronic obstructive pulmonary disease (COPD). Its commercial portfolio includes several first-to-market generic inhalation solutions in China, including levosalbutamol hydrochloride and ipratropium bromide. The company operates advanced manufacturing facilities that comply with rigorous GMP standards for nebulized solutions and dry powder inhalers. By providing high-quality, affordable alternatives to imported blockbuster drugs, it has established itself as a leader in the domestic Chinese respiratory market.